Evidence map›Paper›PMID 35114969›Full record

ArticleBMC public health2022

Who gets vaccinated in a measles-rubella campaign in Nepal?: results from a post-campaign coverage survey.

M Carolina Danovaro-Holliday, Dale A Rhoda, Mona Lacoul, Mary L Prier, Jhalak Sharma Gautam, Tara Nath Pokhrel, Sameer Mani Dixit, Rajesh Man Rajbhandari, Anindya Sekhar Bose

Abstract read
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Vaccination Coverage Quality Indicators (VCQI): a flexible open-source tool for survey data analysis.Revista panamericana de salud publica = Pan American journal of public health · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

M Carolina Danovaro-HollidayDepartment of Immunization, Vaccines and Biologicals (IVB), World Health Organization (WHO), 20, Ave Appia, 1211, Geneva, Switzerland. danovaroc@who.int.ORCID 0000-0001-7324-9198
Dale A RhodaBiostat Global Consulting, Worthington, OH, USA.ORCID 0000-0003-0948-1368
Mona LacoulCountry Office Nepal, WHO, Kathmandu, Nepal.
Mary L PrierBiostat Global Consulting, Worthington, OH, USA.
Jhalak Sharma GautamFamily Welfare Division, Department of Health Services, Government of Nepal, Kathmandu, Nepal.
Tara Nath PokhrelFamily Welfare Division, Department of Health Services, Government of Nepal, Kathmandu, Nepal.
Sameer Mani DixitCenter for Molecular Dynamics (CMDN), Kathmandu, Nepal.
Rajesh Man RajbhandariCenter for Molecular Dynamics (CMDN), Kathmandu, Nepal.
Anindya Sekhar BoseDepartment of Immunization, Vaccines and Biologicals (IVB), World Health Organization (WHO), 20, Ave Appia, 1211, Geneva, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundFollowing the 2015 earthquake, a measles-rubella (MR) supplementary immunization activity (SIA), in four phases, was implemented in Nepal in 2015-2016. A post-campaign coverage survey (PCCS) was then conducted in 2017 to assess SIA performance and explore factors that were associated with vaccine uptake.

methodsA household survey using stratified multi-stage probability sampling was conducted to assess coverage for a MR dose in the 2015-2016 SIA in Nepal. Logistic regression was then used to identify factors related to vaccine uptake.

resultsEleven thousand two hundred fifty-three households, with 4870 eligible children provided information on vaccination during the 2015-2016 MR SIA. Overall coverage of measles-rubella vaccine was 84.7% (95% CI: 82.0-87.0), but varied between 77.5% (95% CI: 72.0, 82.2) in phase-3, of 21 districts vaccinated in Feb-Mar 2016, to 97.7% (CI: 95.4, 98.9) in phase-4, of the last seven mountainous districts vaccinated in Mar-Apr 2016. Coverage in rural areas was higher at 85.6% (CI: 81.9, 88.8) than in urban areas at 79.0% (CI: 75.5, 82.1). Of the 4223 children whose caregivers knew about the SIA, 96.5% received the MR dose and of the 647 children whose caregivers had not heard about the campaign, only 1.8% received the MR dose.

conclusionsThe coverage in the 2015-2016 MR SIA in Nepal varied by geographical region with rural areas achieving higher coverage than urban areas. The single most important predictor of vaccination was the caregiver being informed in advance about the vaccination campaign. Enhanced efforts on social mobilization for vaccination have been used in Nepal since this survey, notably for the most recent 2020 MR campaign.

Indexed as

MeaslesRubellaChildHumansImmunization ProgramsInfantMeasles VaccineNepalRubella VaccineVaccinationMeasles VaccineRubella VaccineImmunizationMeasles-rubellaNepalVaccination campaignVaccination coverage survey

Identifiers

PMID35114969
PMCPMC8812357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.